Market Research Logo

2018-2023 Global Prostate Cancer Medicine Market Report (Status and Outlook)

2018-2023 Global Prostate Cancer Medicine Market Report (Status and Outlook)

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Prostate Cancer Medicine market for 2018-2023.

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.
Over the next five years, LPI(LP Information) projects that Prostate Cancer Medicine will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Prostate Cancer Medicine market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
LHRH Antagonists
LHRH Analogs
Pipeline Drugs for Hormonal Therapy
Segmentation by application:
Hospitals
Other

We can also provide the customized separate regional or country-level reports, for the following regions:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
AstraZeneca plc
Active Biotech
Bristol Myers-Squibb
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Pfizer Inc.
Bayer AG
Abbott Laboratories
Astellas Pharma Inc.
Roche Holding AG

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Prostate Cancer Medicine market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Prostate Cancer Medicine market by identifying its various subsegments.
Focuses on the key global Prostate Cancer Medicine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostate Cancer Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Prostate Cancer Medicine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Cancer Medicine Market Size 2013-2023
2.1.2 Prostate Cancer Medicine Market Size CAGR by Region
2.2 Prostate Cancer Medicine Segment by Type
2.2.1 LHRH Antagonists
2.2.2 LHRH Analogs
2.2.3 Antiandrogens
2.2.4 Pipeline Drugs for Hormonal Therapy
2.3 Prostate Cancer Medicine Market Size by Type
2.3.1 Global Prostate Cancer Medicine Market Size Market Share by Type (2013-2018)
2.3.2 Global Prostate Cancer Medicine Market Size Growth Rate by Type (2013-2018)
2.4 Prostate Cancer Medicine Segment by Application
2.4.1 Hospitals
2.4.2 Other
2.5 Prostate Cancer Medicine Market Size by Application
2.5.1 Global Prostate Cancer Medicine Market Size Market Share by Application (2013-2018)
2.5.2 Global Prostate Cancer Medicine Market Size Growth Rate by Application (2013-2018)
3 Global Prostate Cancer Medicine by Players
3.1 Global Prostate Cancer Medicine Market Size Market Share by Players
3.1.1 Global Prostate Cancer Medicine Market Size by Players (2016-2018)
3.1.2 Global Prostate Cancer Medicine Market Size Market Share by Players (2016-2018)
3.2 Global Prostate Cancer Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prostate Cancer Medicine by Regions
4.1 Prostate Cancer Medicine Market Size by Regions
4.2 Americas Prostate Cancer Medicine Market Size Growth
4.3 APAC Prostate Cancer Medicine Market Size Growth
4.4 Europe Prostate Cancer Medicine Market Size Growth
4.5 Middle East & Africa Prostate Cancer Medicine Market Size Growth
5 Americas
5.1 Americas Prostate Cancer Medicine Market Size by Countries
5.2 Americas Prostate Cancer Medicine Market Size by Type
5.3 Americas Prostate Cancer Medicine Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Prostate Cancer Medicine Market Size by Countries
6.2 APAC Prostate Cancer Medicine Market Size by Type
6.3 APAC Prostate Cancer Medicine Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Prostate Cancer Medicine by Countries
7.2 Europe Prostate Cancer Medicine Market Size by Type
7.3 Europe Prostate Cancer Medicine Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Prostate Cancer Medicine by Countries
8.2 Middle East & Africa Prostate Cancer Medicine Market Size by Type
8.3 Middle East & Africa Prostate Cancer Medicine Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Prostate Cancer Medicine Market Forecast
10.1 Global Prostate Cancer Medicine Market Size Forecast (2018-2023)
10.2 Global Prostate Cancer Medicine Forecast by Regions
10.2.1 Global Prostate Cancer Medicine Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Prostate Cancer Medicine Forecast by Type
10.8 Global Prostate Cancer Medicine Forecast by Application
11 Key Players Analysis
11.1 AstraZeneca plc
11.1.1 Company Details
11.1.2 Prostate Cancer Medicine Product Offered
11.1.3 AstraZeneca plc Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 AstraZeneca plc News
11.2 Active Biotech
11.2.1 Company Details
11.2.2 Prostate Cancer Medicine Product Offered
11.2.3 Active Biotech Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Active Biotech News
11.3 Bristol Myers-Squibb
11.3.1 Company Details
11.3.2 Prostate Cancer Medicine Product Offered
11.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Bristol Myers-Squibb News
11.4 Teva Pharmaceuticals Industries Ltd.
11.4.1 Company Details
11.4.2 Prostate Cancer Medicine Product Offered
11.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Teva Pharmaceuticals Industries Ltd. News
11.5 Johnson & Johnson
11.5.1 Company Details
11.5.2 Prostate Cancer Medicine Product Offered
11.5.3 Johnson & Johnson Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Johnson & Johnson News
11.6 Pfizer Inc.
11.6.1 Company Details
11.6.2 Prostate Cancer Medicine Product Offered
11.6.3 Pfizer Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Pfizer Inc. News
11.7 Bayer AG
11.7.1 Company Details
11.7.2 Prostate Cancer Medicine Product Offered
11.7.3 Bayer AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Bayer AG News
11.8 Abbott Laboratories
11.8.1 Company Details
11.8.2 Prostate Cancer Medicine Product Offered
11.8.3 Abbott Laboratories Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Abbott Laboratories News
11.9 Astellas Pharma Inc.
11.9.1 Company Details
11.9.2 Prostate Cancer Medicine Product Offered
11.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Astellas Pharma Inc. News
11.10 Roche Holding AG
11.10.1 Company Details
11.10.2 Prostate Cancer Medicine Product Offered
11.10.3 Roche Holding AG Prostate Cancer Medicine Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Roche Holding AG News
12 Research Findings and Conclusion
List of Tables and Figures
Table Product Specifications of Prostate Cancer Medicine
Figure Prostate Cancer Medicine Report Years Considered
Figure Market Research Methodology
Figure Global Prostate Cancer Medicine Market Size Growth Rate 2013-2023 ($ Millions)
Table Prostate Cancer Medicine Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of LHRH Antagonists
Table Major Players of LHRH Analogs
Table Major Players of Antiandrogens
Table Major Players of Pipeline Drugs for Hormonal Therapy
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Prostate Cancer Medicine Market Size Market Share by Type (2013-2018)
Figure Global Prostate Cancer Medicine Market Size Market Share by Type (2013-2018)
Figure Global LHRH Antagonists Market Size Growth Rate
Figure Global LHRH Analogs Market Size Growth Rate
Figure Global Antiandrogens Market Size Growth Rate
Figure Global Pipeline Drugs for Hormonal Therapy Market Size Growth Rate
Figure Prostate Cancer Medicine Consumed in Hospitals
Figure Global Prostate Cancer Medicine Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Prostate Cancer Medicine Consumed in Other
Figure Global Prostate Cancer Medicine Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Prostate Cancer Medicine Market Size by Application (2013-2018) ($ Millions)
Table Global Prostate Cancer Medicine Market Size Market Share by Application (2013-2018)
Figure Global Prostate Cancer Medicine Market Size Market Share by Application (2013-2018)
Figure Global Prostate Cancer Medicine Market Size in Hospitals Growth Rate
Figure Global Prostate Cancer Medicine Market Size in Other Growth Rate
Table Global Prostate Cancer Medicine Revenue by Players (2016-2018) ($ Millions)
Table Global Prostate Cancer Medicine Revenue Market Share by Players (2016-2018)
Figure Global Prostate Cancer Medicine Revenue Market Share by Players in 2017
Table Global Prostate Cancer Medicine Key Players Head office and Products Offered
Table Prostate Cancer Medicine Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Prostate Cancer Medicine Market Size by Regions 2013-2018 ($ Millions)
Table Global Prostate Cancer Medicine Market Size Market Share by Regions 2013-2018
Figure Global Prostate Cancer Medicine Market Size Market Share by Regions 2013-2018
Figure Americas Prostate Cancer Medicine Market Size 2013-2018 ($ Millions)
Figure APAC Prostate Cancer Medicine Market Size 2013-2018 ($ Millions)
Figure Europe Prostate Cancer Medicine Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Prostate Cancer Medicine Market Size 2013-2018 ($ Millions)
Table Americas Prostate Cancer Medicine Market Size by Countries (2013-2018) ($ Millions)
Table Americas Prostate Cancer Medicine Market Size Market Share by Countries (2013-2018)
Figure Americas Prostate Cancer Medicine Market Size Market Share by Countries in 2017
Table Americas Prostate Cancer Medicine Market Size by Type (2013-2018) ($ Millions)
Table Americas Prostate Cancer Medicine Market Size Market Share by Type (2013-2018)
Figure Americas Prostate Cancer Medicine Market Size Market Share by Type in 2017
Table Americas Prostate Cancer Medicine Market Size by Application (2013-2018) ($ Millions)
Table Americas Prostate Cancer Medicine Market Size Market Share by Application (2013-2018)
Figure Americas Prostate Cancer Medicine Market Size Market Share by Application in 2017
Figure United States Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Canada Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Table APAC Prostate Cancer Medicine Market Size by Countries (2013-2018) ($ Millions)
Table APAC Prostate Cancer Medicine Market Size Market Share by Countries (2013-2018)
Figure APAC Prostate Cancer Medicine Market Size Market Share by Countries in 2017
Table APAC Prostate Cancer Medicine Market Size by Type (2013-2018) ($ Millions)
Table APAC Prostate Cancer Medicine Market Size Market Share by Type (2013-2018)
Figure APAC Prostate Cancer Medicine Market Size Market Share by Type in 2017
Table APAC Prostate Cancer Medicine Market Size by Application (2013-2018) ($ Millions)
Table APAC Prostate Cancer Medicine Market Size Market Share by Application (2013-2018)
Figure APAC Prostate Cancer Medicine Market Size Market Share by Application in 2017
Figure China Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Japan Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Korea Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure India Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Australia Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Table Europe Prostate Cancer Medicine Market Size by Countries (2013-2018) ($ Millions)
Table Europe Prostate Cancer Medicine Market Size Market Share by Countries (2013-2018)
Figure Europe Prostate Cancer Medicine Market Size Market Share by Countries in 2017
Table Europe Prostate Cancer Medicine Market Size by Type (2013-2018) ($ Millions)
Table Europe Prostate Cancer Medicine Market Size Market Share by Type (2013-2018)
Figure Europe Prostate Cancer Medicine Market Size Market Share by Type in 2017
Table Europe Prostate Cancer Medicine Market Size by Application (2013-2018) ($ Millions)
Table Europe Prostate Cancer Medicine Market Size Market Share by Application (2013-2018)
Figure Europe Prostate Cancer Medicine Market Size Market Share by Application in 2017
Figure Germany Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure France Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure UK Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Italy Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Russia Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Spain Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Prostate Cancer Medicine Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Prostate Cancer Medicine Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Prostate Cancer Medicine Market Size Market Share by Countries in 2017
Table Middle East & Africa Prostate Cancer Medicine Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Prostate Cancer Medicine Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Prostate Cancer Medicine Market Size Market Share by Type in 2017
Table Middle East & Africa Prostate Cancer Medicine Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Prostate Cancer Medicine Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Prostate Cancer Medicine Market Size Market Share by Application in 2017
Figure Egypt Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Israel Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Prostate Cancer Medicine Market Size Growth 2013-2018 ($ Millions)
Figure Global Prostate Cancer Medicine arket Size Forecast (2018-2023) ($ Millions)
Table Global Prostate Cancer Medicine Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Prostate Cancer Medicine Market Size Market Share Forecast by Regions
Figure Americas Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure APAC Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Europe Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure United States Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Canada Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Mexico Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Brazil Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure China Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Japan Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Korea Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure India Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Australia Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Germany Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure France Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure UK Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Italy Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Russia Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Spain Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Egypt Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure South Africa Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Israel Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure Turkey Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Figure GCC Countries Prostate Cancer Medicine Market Size 2018-2023 ($ Millions)
Table Global Prostate Cancer Medicine Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Prostate Cancer Medicine Market Size Market Share Forecast by Type (2018-2023)
Table Global Prostate Cancer Medicine Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Prostate Cancer Medicine Market Size Market Share Forecast by Application (2018-2023)
Table AstraZeneca plc Basic Information, Head Office, Major Market Areas and Its Competitors
Table AstraZeneca plc Prostate Cancer Medicine Revenue and Gross Margin (2016-2018)
Figure AstraZeneca plc Prostate Cancer Medicine Market Share (2016-2018)
Table Active Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table Active Biotech Prostate Cancer Medicine Revenue and Gross Margin (2016-2018)
Figure Active Biotech Prostate Cancer Medicine Market Share (2016-2018)
Table Bristol Myers-Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol Myers-Squibb Prostate Cancer Medicine Revenue and Gross Margin (2016-2018)
Figure Bristol Myers-Squibb Prostate Cancer Medicine Market Share (2016-2018)
Table Teva Pharmaceuticals Industries Ltd. Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue and Gross Margin (2016-2018)
Figure Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table Johnson & Johnson Prostate Cancer Medicine Revenue and Gross Margin (2016-2018)
Figure Johnson & Johnson Prostate Cancer Medicine Market Share (2016-2018)
Table Pfizer Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Inc. Prostate Cancer Medicine Revenue and Gross Margin (2016-2018)
Figure Pfizer Inc. Prostate Cancer Medicine Market Share (2016-2018)
Table Bayer AG Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bayer AG Prostate Cancer Medicine Revenue and Gross Margin (2016-2018)
Figure Bayer AG Prostate Cancer Medicine Market Share (2016-2018)
Table Abbott Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table Abbott Laboratories Prostate Cancer Medicine Revenue and Gross Margin (2016-2018)
Figure Abbott Laboratories Prostate Cancer Medicine Market Share (2016-2018)
Table Astellas Pharma Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table Astellas Pharma Inc. Prostate Cancer Medicine Revenue and Gross Margin (2016-2018)
Figure Astellas Pharma Inc. Prostate Cancer Medicine Market Share (2016-2018)
Table Roche Holding AG Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Holding AG Prostate Cancer Medicine Revenue and Gross Margin (2016-2018)
Figure Roche Holding AG Prostate Cancer Medicine Market Share (2016-2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report